The significant elevation of XBP1 in patients with severe COVID-19 is important for the provision of additional extracellular amino acids, mitochondrial anaplerosis and cataplerosis, and subsequent sustained antibody secretion (47, 48). Here, XBP1 is linked to COVID-19.